{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:10:16Z","timestamp":1789992616724,"version":"4.0.1"},"reference-count":21,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Functional impairment is common in older adults with cancer and may influence treatment outcomes. This study aimed to evaluate the prognostic value of objectively measured functional mobility, with gait speed as the primary analytical variable, for survival, treatment response, and chemotherapy-related toxicity in geriatric cancer patients. Materials and Methods: In this single-center prospective study, 102 patients aged 65 years and older who were chemotherapy-naive were enrolled. Before treatment initiation, functional mobility was assessed using a 3-m gait-speed test at the patient\u2019s usual pace. Gait speed was analyzed primarily as a continuous variable; the sample-median cutoff was retained for secondary descriptive analyses, and 0.8 m\/s was evaluated in a sensitivity analysis. Associations with survival, treatment response, and toxicity were evaluated using survival and regression analyses. Results: The mean gait speed was 0.481 \u00b1 0.176 m\/s. Among patients with metastatic disease, higher continuous gait speed was associated with lower mortality in univariable analysis (HR = 0.752, 95% CI: 0.605\u20130.934, p = 0.010) and after adjustment for age, sex, and ECOG performance status (adjusted HR = 0.647, 95% CI: 0.490\u20130.853, p = 0.002). Gait speed was not significantly associated with metastatic PFS, non-metastatic OS or DFS, or grade \u2265 3 toxicity. The 0.8 m\/s sensitivity analysis was limited by marked group imbalance. Conclusions: Higher baseline gait speed was associated with lower mortality in metastatic geriatric cancer patients, whereas statistically significant associations were not detected for PFS, non-metastatic survival outcomes, or grade \u2265 3 toxicity. These exploratory findings require validation in larger and more homogeneous cohorts.<\/jats:p>","DOI":"10.3390\/medicina62091815","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:25:43Z","timestamp":1789986343000},"page":"1815","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional Mobility as a Prognostic Marker in Geriatric Oncology: A Prospective Study Using Gait Speed"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-0277","authenticated-orcid":false,"given":"Beyza","family":"\u00dcnl\u00fc","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sena Ece","family":"Davarc\u0131","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0317-7552","authenticated-orcid":false,"given":"Ya\u015far","family":"Culha","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sivas Numune Hospital, Sivas 58050, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3291-8134","authenticated-orcid":false,"given":"Meltem","family":"Baykara","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global cancer statistics 2020","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: Evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. A"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2004.12.026","article-title":"The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: A population-based study","volume":"97","author":"Maas","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/COC.0000000000000488","article-title":"How to optimize cancer treatment in older patients: An overview of available geriatric tools","volume":"42","author":"Pamoukdjian","year":"2019","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_5","first-page":"308","article-title":"Comprehensive geriatric assessment adds information to ECOG performance status in elderly cancer patients","volume":"13","author":"Repetto","year":"2002","journal-title":"Ann. Oncol."},{"key":"ref_6","first-page":"585","article-title":"Use of comprehensive geriatric assessment in older cancer patients","volume":"6","author":"Extermann","year":"2005","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment","volume":"32","author":"Wildiers","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer","volume":"29","author":"Hurria","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_9","first-page":"1626","article-title":"Screening for vulnerability in older cancer patients","volume":"32","author":"Soubeyran","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jama.2010.1923","article-title":"Gait speed and survival in older adults","volume":"305","author":"Studenski","year":"2011","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s12603-009-0246-z","article-title":"Gait speed at usual pace as a predictor of adverse outcomes","volume":"13","author":"Rolland","year":"2009","journal-title":"J. Nutr. Health Aging"},{"key":"ref_12","first-page":"1444","article-title":"Prognostic value of usual gait speed","volume":"293","author":"Cesari","year":"2005","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1532-5415.2007.01413.x","article-title":"Improvement in gait speed predicts survival","volume":"55","author":"Hardy","year":"2007","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jgo.2015.08.006","article-title":"Measurement of gait speed in older adults","volume":"6","author":"Pamoukdjian","year":"2015","journal-title":"J. Geriatr. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jgo.2017.02.003","article-title":"Gait speed and early mortality in older cancer patients","volume":"8","author":"Pamoukdjian","year":"2017","journal-title":"J. Geriatr. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/cncr.33344","article-title":"Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment","volume":"127","author":"Hantel","year":"2021","journal-title":"Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood.2021013671","article-title":"Geriatric assessment predicts nonfatal toxicities and survival for intensively treated older adults with AML","volume":"139","author":"Min","year":"2022","journal-title":"Blood"},{"key":"ref_18","first-page":"189","article-title":"Comparison of Mobility Indices for Predicting Early Death in Older Patients with Cancer: The Physical Frailty in Elderly Cancer Cohort Study","volume":"75","author":"Pamoukdjian","year":"2019","journal-title":"J. Gerontol. Ser. A-Biol. Sci. Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Stokke, K., Halvorsen, T.O., Gr\u00f8nberg, B.H., Saltvedt, I., Slaaen, M., Kirkevold, \u00d8., Killingberg, K.T., and Sandvei, M.S. (2022). Associations between measured and patient-reported physical function and survival in advanced NSCLC. Healthcare, 10.","DOI":"10.3390\/healthcare10050922"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Aregui, A., Pluvy, J., Sanchez, M., Israel, T., Esnault, H., Guyard, A., Meyer, M., Khalil, A., Zalcman, G., and Simon, A.R. (2022). Measuring Walking Speed Failed to Predict Early Death and Toxicity in Elderly Patients with Metastatic Non-Small-Cell Lung Cancer (NSCLC) Selected for Undergoing First-Line Systemic Treatment: An Observational Exploratory Study. Cancers, 14.","DOI":"10.3390\/cancers14051344"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2012-12-471680","article-title":"Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia","volume":"121","author":"Klepin","year":"2013","journal-title":"Blood"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1815\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:29:21Z","timestamp":1789990161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["medicina62091815"],"URL":"https:\/\/doi.org\/10.3390\/medicina62091815","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}